Research hypothesis | Conclusion | |
---|---|---|
H1 (Engagement âž” Perceived benefits) | When stakeholders are more engaged with modern biotechnology, then they will perceive higher benefits associated with biobanks. | Supported |
H2 (Engagement âž” Issues of data & specimen protection) | When stakeholders are more engaged with biotechnology, then they will exhibit less concern regarding issues of data and specimen protection in biobanks. | Not Supported |
H3 (Engagement âž” Religious acceptance) | When stakeholders are more engaged with biotechnology, then they will be more accepting of biobanks from a religious perspective. | Supported |
H4 (Engagement âž” Willingness to participate) | When stakeholders are more engaged with biotechnology, then they will be more willing to participate in biobanking. | Not Supported |
H5 (Trust in key players âž” Perceived benefits) | When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will perceive stronger benefits associated with biobanks. | Supported |
H6 (Trust in key players âž” Issues of data & specimen protection) | When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will exhibit lower concerns regarding issues of data and specimen protection in biobanks. | Not Supported |
H7 (Trust in key players âž” Religious acceptance) | When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will be more accepting of biobanks from a religious perspective. | Not Supported |
H8 (Trust in key players âž” Willingness to participate) | When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will be more willing to participate in biobanking. | Supported |
H9 (Attitude towards technology âž” Issues of data & specimen protection) | When stakeholders exhibit a strong negative predisposition towards science and technology, then they will exhibit stronger concerns regarding issues of data and specimen protection in biobanks. | Supported |
H10 (Attitude towards technology âž” Religious acceptance) | When stakeholders exhibit a strong negative predisposition towards science and technology, then they will be less accepting of biobanks from a religious perspective. | Not Supported |
H11 (Religiosity âž” Perceived benefits) | When stakeholders view themselves are more religious, then they will perceive stronger benefits associated with biobanks. | Supported |
H12 (Religiosity âž” Issues of data & specimen protection) | When stakeholders view themselves as more religious, then they will exhibit stronger concerns regarding issues of data and specimen protection in biobanks. | Supported |
H13 (Religiosity âž” Willingness to participate) | When stakeholders view themselves as more religious, then they will be more willing to participate in biobanking. | Not Supported |
H14 (Issues of data & specimen protection âž” Perceived benefits) | When stakeholders have strong concerns regarding issues of data and specimen protection associated with biobanks, then they will perceive fewer benefits associated with biobanks. | Not Supported |
H15 (Issues of data & specimen protection âž” Religious acceptance) | When stakeholders have stronger concerns regarding issues of data and specimen protection associated with biobanks, then they will be less accepting of biobanks from a religious perspective. | Supported |
H16 (Issues of data & specimen protection âž” Willingness to participate) | When stakeholders have strong concerns about issues of data and specimen protection associated with biobanks, then they will be less willing to participate in biobanking. | Supported |
H17 (Perceived benefits âž” Religious acceptance) | When stakeholders perceive stronger benefits associated with biobanks, then they will be more accepting of biobanks from a religious perspective. | Supported |
H18 (Perceived benefits âž” Willingness to participate) | When stakeholders perceive stronger benefits associated with biobanks, then they be more willing to participate in biobanking. | Supported |
H19 (Religious acceptance âž” Willingness to participate) | When stakeholders are more accepting of biobanks from a religious perspective, then they will be more willing to participate in biobanking. | Supported |